tiprankstipranks
Trending News
More News >
IGC Pharma (IGC)
:IGC
US Market

IGC Pharma (IGC) Income Statement

Compare
913 Followers

IGC Pharma Income Statement

Last quarter (Q4 2025), IGC Pharma's total revenue was $330.00K, an increase of 11.86% from the same quarter last year. In Q4, IGC Pharma's net income was $-1.20M. See IGC Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 1.27M$ 1.34M$ 911.00K$ 397.00K$ 898.00K
Gross Profit
$ 619.00K$ 733.00K$ 442.00K$ 194.00K$ 113.00K
Operating Expenses
$ 8.06M$ 10.53M$ 12.01M$ 15.62M$ 8.84M
Depreciation and Amortization
$ 618.00K$ 637.00K$ 657.00K$ 651.00K$ 478.00K
EBITDA
$ -6.83M$ -9.16M$ -10.91M$ -14.78M$ -8.25M
Operating Income
$ -7.45M$ -9.80M$ -11.57M$ -15.43M$ -8.72M
Other Income/Expenses
$ 325.00K$ -3.20M$ 65.00K$ 412.00K$ -87.00K
Pretax Income
$ -7.12M$ -13.00M$ -11.51M$ -15.02M$ -8.81M
Net Income
$ -7.12M$ -13.00M$ -11.51M$ -15.02M$ -8.81M
Per Share Metrics
Basic EPS
$ -0.09$ -0.22$ -0.22$ -0.30$ -0.21
Diluted EPS
$ -0.09$ -0.22$ -0.22$ -0.30$ -0.21
Weighted Average Shares Outstanding
76.52M 58.84M 52.58M 49.99M 41.96M
Weighted Average Shares Outstanding (Diluted)
76.52M 58.84M 52.58M 49.99M 41.96M
Currency in USD

IGC Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis